1542 related articles for article (PubMed ID: 29701561)
1. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial.
Derakhshanrad N; Saberi H; Yekaninejad MS; Joghataei MT; Sheikhrezaei A
J Neurosurg Spine; 2018 Jul; 29(1):97-107. PubMed ID: 29701561
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous granulocyte colony-stimulating factor administration for subacute traumatic spinal cord injuries, report of neurological and functional outcomes: a double-blind randomized controlled clinical trial.
Derakhshanrad N; Saberi H; Yekaninejad MS; Joghataei MT
J Neurosurg Spine; 2018 Oct; 30(1):19-30. PubMed ID: 30497202
[TBL] [Abstract][Full Text] [Related]
3. Comparison of neurological and functional outcomes after administration of granulocyte-colony-stimulating factor in motor-complete versus motor-incomplete postrehabilitated, chronic spinal cord injuries: a phase I/II study.
Saberi H; Derakhshanrad N; Yekaninejad MS
Cell Transplant; 2014; 23 Suppl 1():S19-23. PubMed ID: 25302604
[TBL] [Abstract][Full Text] [Related]
4. Safety of granulocyte colony-stimulating factor (G-CSF) administration for postrehabilitated motor complete spinal cord injury patients: an open-label, phase I study.
Derakhshanrad N; Saberi H; Yekaninejad MS; Eskandari G; Mardani A; Rahdari F; Meybodi KT
Cell Transplant; 2013; 22 Suppl 1():S139-46. PubMed ID: 23992648
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of granulocyte colony-stimulating factor for spinal cord injury.
Koda M; Hanaoka H; Fujii Y; Hanawa M; Kawasaki Y; Ozawa Y; Fujiwara T; Furuya T; Ijima Y; Saito J; Kitamura M; Miyamoto T; Ohtori S; Matsumoto Y; Abe T; Takahashi H; Watanabe K; Hirano T; Ohashi M; Shoji H; Mizouchi T; Kawahara N; Kawaguchi M; Orita Y; Sasamoto T; Yoshioka M; Fujii M; Yonezawa K; Soma D; Taneichi H; Takeuchi D; Inami S; Moridaira H; Ueda H; Asano F; Shibao Y; Aita I; Takeuchi Y; Mimura M; Shimbo J; Someya Y; Ikenoue S; Sameda H; Takase K; Ikeda Y; Nakajima F; Hashimoto M; Hasue F; Fujiyoshi T; Kamiya K; Watanabe M; Katoh H; Matsuyama Y; Hasegawa T; Yoshida G; Arima H; Yamato Y; Oe S; Togawa D; Kobayashi S; Akeda K; Kawamoto E; Imai H; Sakakibara T; Sudo A; Ito Y; Kikuchi T; Takigawa T; Morita T; Tanaka N; Nakanishi K; Kamei N; Kotaka S; Baba H; Okudaira T; Konishi H; Yamaguchi T; Ito K; Katayama Y; Matsumoto T; Matsumoto T; Kanno H; Aizawa T; Hashimoto K; Eto T; Sugaya T; Matsuda M; Fushimi K; Nozawa S; Iwai C; Taguchi T; Kanchiku T; Suzuki H; Nishida N; Funaba M; Sakai T; Imajo Y; Yamazaki M
Brain; 2021 Apr; 144(3):789-799. PubMed ID: 33764445
[TBL] [Abstract][Full Text] [Related]
6. Multicenter prospective nonrandomized controlled clinical trial to prove neurotherapeutic effects of granulocyte colony-stimulating factor for acute spinal cord injury: analyses of follow-up cases after at least 1 year.
Inada T; Takahashi H; Yamazaki M; Okawa A; Sakuma T; Kato K; Hashimoto M; Hayashi K; Furuya T; Fujiyoshi T; Kawabe J; Mannoji C; Miyashita T; Kadota R; Someya Y; Ikeda O; Hashimoto M; Suda K; Kajino T; Ueda H; Ito Y; Ueta T; Hanaoka H; Takahashi K; Koda M
Spine (Phila Pa 1976); 2014 Feb; 39(3):213-9. PubMed ID: 24299727
[TBL] [Abstract][Full Text] [Related]
7. Study protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injury.
Koda M; Hanaoka H; Sato T; Fujii Y; Hanawa M; Takahashi S; Furuya T; Ijima Y; Saito J; Kitamura M; Ohtori S; Matsumoto Y; Abe T; Watanabe K; Hirano T; Ohashi M; Shoji H; Mizouchi T; Takahashi I; Kawahara N; Kawaguchi M; Orita Y; Sasamoto T; Yoshioka M; Fujii M; Yonezawa K; Soma D; Taneichi H; Takeuchi D; Inami S; Moridaira H; Ueda H; Asano F; Shibao Y; Aita I; Takeuchi Y; Mimura M; Shimbo J; Someya Y; Ikenoue S; Sameda H; Takase K; Ikeda Y; Nakajima F; Hashimoto M; Ozawa T; Hasue F; Fujiyoshi T; Kamiya K; Watanabe M; Katoh H; Matsuyama Y; Yamamoto Y; Togawa D; Hasegawa T; Kobayashi S; Yoshida G; Oe S; Banno T; Arima H; Akeda K; Kawamoto E; Imai H; Sakakibara T; Sudo A; Ito Y; Kikuchi T; Osaki S; Tanaka N; Nakanishi K; Kamei N; Kotaka S; Baba H; Okudaira T; Konishi H; Yamaguchi T; Ito K; Katayama Y; Matsumoto T; Matsumoto T; Idota M; Kanno H; Aizawa T; Hashimoto K; Eto T; Sugaya T; Matsuda M; Fushimi K; Nozawa S; Iwai C; Taguchi T; Kanchiku T; Suzuki H; Nishida N; Funaba M; Yamazaki M
BMJ Open; 2018 May; 8(5):e019083. PubMed ID: 29730616
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury.
Huang H; Xi H; Chen L; Zhang F; Liu Y
Cell Transplant; 2012; 21 Suppl 1():S23-31. PubMed ID: 22507677
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trial.
Takahashi H; Yamazaki M; Okawa A; Sakuma T; Kato K; Hashimoto M; Hayashi K; Furuya T; Fujiyoshi T; Kawabe J; Yamauchi T; Mannoji C; Miyashita T; Kadota R; Hashimoto M; Ito Y; Takahashi K; Koda M
Eur Spine J; 2012 Dec; 21(12):2580-7. PubMed ID: 22391867
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Trial.
Fehlings MG; Moghaddamjou A; Harrop JS; Stanford R; Ball J; Aarabi B; Freeman BJC; Arnold PM; Guest JD; Kurpad SN; Schuster JM; Nassr A; Schmitt KM; Wilson JR; Brodke DS; Ahmad FU; Yee A; Ray WZ; Brooks NP; Wilson J; Chow DS; Toups EG; Kopjar B
J Neurotrauma; 2023 Sep; 40(17-18):1878-1888. PubMed ID: 37279301
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective therapy with granulocyte colony-stimulating factor in acute spinal cord injury: a comparison with high-dose methylprednisolone as a historical control.
Kamiya K; Koda M; Furuya T; Kato K; Takahashi H; Sakuma T; Inada T; Ota M; Maki S; Okawa A; Ito Y; Takahashi K; Yamazaki M
Eur Spine J; 2015 May; 24(5):963-7. PubMed ID: 24961222
[TBL] [Abstract][Full Text] [Related]
12. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on glial scar formation after spinal cord injury in rats.
Chung J; Kim MH; Yoon YJ; Kim KH; Park SR; Choi BH
J Neurosurg Spine; 2014 Dec; 21(6):966-73. PubMed ID: 25279652
[TBL] [Abstract][Full Text] [Related]
13. Is the outcome in acute spinal cord ischaemia different from that in traumatic spinal cord injury? A cross-sectional analysis of the neurological and functional outcome in a cohort of 93 paraplegics.
Pouw MH; Hosman AJ; van Kampen A; Hirschfeld S; Thietje R; van de Meent H
Spinal Cord; 2011 Feb; 49(2):307-12. PubMed ID: 20805834
[TBL] [Abstract][Full Text] [Related]
14. Acidic fibroblast growth factor for repair of human spinal cord injury: a clinical trial.
Wu JC; Huang WC; Chen YC; Tu TH; Tsai YA; Huang SF; Huang HC; Cheng H
J Neurosurg Spine; 2011 Sep; 15(3):216-27. PubMed ID: 21663406
[TBL] [Abstract][Full Text] [Related]
15. Delayed granulocyte colony-stimulating factor treatment promotes functional recovery in rats with severe contusive spinal cord injury.
Lee JS; Yang CC; Kuo YM; Sze CI; Hsu JY; Huang YH; Tzeng SF; Tsai CL; Chen HH; Jou IM
Spine (Phila Pa 1976); 2012 Jan; 37(1):10-7. PubMed ID: 22024901
[TBL] [Abstract][Full Text] [Related]
16. The hematopoietic factor granulocyte-colony stimulating factor improves outcome in experimental spinal cord injury.
Pitzer C; Klussmann S; Krüger C; Letellier E; Plaas C; Dittgen T; Kirsch F; Stieltjes B; Weber D; Laage R; Martin-Villalba A; Schneider A
J Neurochem; 2010 May; 113(4):930-42. PubMed ID: 20202082
[TBL] [Abstract][Full Text] [Related]
17. Against the odds: what to expect in rehabilitation of chronic spinal cord injury with a neurologically controlled Hybrid Assistive Limb exoskeleton. A subgroup analysis of 55 patients according to age and lesion level.
Grasmücke D; Zieriacks A; Jansen O; Fisahn C; Sczesny-Kaiser M; Wessling M; Meindl RC; Schildhauer TA; Aach M
Neurosurg Focus; 2017 May; 42(5):E15. PubMed ID: 28463613
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial.
Eapen A; Joing M; Kwon P; Tong J; Maneta E; De Santo C; Mussai F; Lissauer D; Carter D;
Hum Reprod; 2019 Mar; 34(3):424-432. PubMed ID: 30776296
[TBL] [Abstract][Full Text] [Related]
19. Functional impact of multidisciplinary outpatient program on patients with chronic complete spinal cord injury.
Derakhshanrad N; Vosoughi F; Yekaninejad MS; Moshayedi P; Saberi H
Spinal Cord; 2015 Dec; 53(12):860-5. PubMed ID: 26238316
[TBL] [Abstract][Full Text] [Related]
20. Combination of bone marrow stromal cell transplantation with mobilization by granulocyte-colony stimulating factor promotes functional recovery after spinal cord transection.
Luo J; Zhang HT; Jiang XD; Xue S; Ke YQ
Acta Neurochir (Wien); 2009 Nov; 151(11):1483-92. PubMed ID: 19499175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
